Botanical Solution Inc.

ChileHealthtech

Botanical Solution Inc. (BSI) is a Chilean biotech company that produces Advanced Botanical Materials (ABM) using a proprietary plant tissue culture platform, enabling sustainable production of solutions for human and plant health without sourcing raw materials from nature or conventional plantations. Its first large-scale ABM is derived from Quillaja saponaria, used to create the biofungicide Quillibrium® for agriculture and the vaccine adjuvant QS-21, a critical component in FDA-approved vaccines for shingles, malaria, RSV, and COVID, with potential applications in cancer immunotherapy. BSI serves the pharmaceutical and agricultural sectors, operating labs and offices in Davis, California and Santiago, Chile. The company secured $7.6 million in a Series A extension round, reflecting investor confidence in its technology and market traction.

Website

1 funding rounds tracked. Amounts, dates and investors are available to premium members.
Unlock full funding history

Key people

Gastón Salinas Co-founder and CEO
Gustavo Zuniga Co-founder